Showing 3761-3770 of 4902 results for "".
MelaFind in Practice: Real-Time Insights
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melafind-in-practice-real-time-insights/22969/MelaFind helps dermatologists to be more accurate, but it also serves the dual function of preventing unnecessary biopsies.New Therapeutic Options for the Treatment of Psoriatic Arthritis: IL-17 Blockers
https://practicaldermatology.com/topics/psoriasis/new-therapeutic-options-for-the-treatment-of-psoriatic-arthritis-il-17-blockers/20447/Are TNF inhibitors still the gold standard for PsA?TNF Inhibitors and the Risk of Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/tnf-inhibitors-and-the-risk-of-melanoma/21519/New research offers a deeper look into the potential elevated risk for malignant melanoma from TNF treatment.ICD-10: Facts, Myths, and Solutions
https://practicaldermatology.com/topics/practice-management/facts-mythsand-solutions/21422/With the deadline for implementation of the new Medicare coding system just months away, physicians need to prepare their practices for a significant transition.Re-Considering the Psychological Components of Psoriasis
https://practicaldermatology.com/topics/psoriasis/re-considering-the-psychological-components-of-psoriasis/22962/With convincing data that show that psoriasis directly inhibits patients' daily activities and quality of life, clinicians must emphasize trust and empathy.Malassezia Sensitization in Head and Neck Atopic Dermatitis: A Meta-Analysis of Prevalence and Diagnostic Markers
https://practicaldermatology.com/topics/atopic-dermatitis/malassezia-sensitization-in-head-and-neck-atopic-dermatitis-a-meta-analysis-of-prevalence-and-diagnostic-markers/57253/In the 2024 study by See Tow and Yew entitled, “Malassezia specific IgE in head and neck dermatitis of eczema: A systematic review & meta-analysis,” the authors found no statistically significant differences in prevalence of dominant Malassezia species but concluded that Malassezia-specific IgERedefining the Discourse: Psoriasis in Diverse Skin Tones
https://practicaldermatology.com/topics/psoriasis/redefining-the-discourse-psoriasis-in-diverse-skin-tones/23856/A lack of representation for underserved ethno-racial groups in clinical data and research is an underlying factor contributing to physicians’ challenges with effectively diagnosing and treating psoriasis in patients with diverse skin tones.Psoriasis and the Metabolic Syndrome
https://practicaldermatology.com/topics/psoriasis/psoriasis-and-the-metabolic-syndrome/21535/Growing data support the notion that TNF inhibitors may decrease various risk factors for the metabolic syndrome.Examining the Implications of Stage 2 of the EHR Incentive Program
https://practicaldermatology.com/topics/practice-management/examining-the-implications-of-stage-2-of-the-ehr-incentive-program/21564/Requirements for patient involvement via portals may spell headaches for physicians hoping to qualify for government incentives in 2014.Combination Biologic and GLP-1 Receptor Agonist Therapy in Psoriasis
https://practicaldermatology.com/topics/psoriasis/combination-biologic-and-glp-1-receptor-agonist-therapy-in-psoriasis/60858/New evidence indicates benefits of a dual-treatment strategy for many patients.